Carcinoma-induced vasculitis (Q96634): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed an Item
 
(6 intermediate revisions by the same user not shown)
description / pt-brdescription / pt-br
 
O surgimento de malignidade é relatado em até 5% dos pacientes com vasculite. Em pacientes com malignidade e vasculite, as meoplasias hematológicas são mais comuns. A vasculite também pode estar associada a tumores sólidos: câncer de rim, mama, ovário, pulmão, nasofaringe, estômago, intestino delgado, cólon e próstata. A vasculite leucocitoclástica é mais comum na vasculite induzida por malignidade, mas a vasculite de grandes vasos também pode surgir. A vasculite paraneoplásica deve ser sempre considerada, para realizar o diagnóstico precoce e o tratamento oportuno da malignidade subjacente. A maioria das vasculites paraneoplásicas não requer tratamento específico além daquele para a malignidade original.
description / endescription / en
 
Emergence of malignancy is reported in up to 5% of patients with vasculitis. In patients with malignancy and vasculitis, hematologic malignancies are most common. Vasculitis can also be associated with solid tumours: kidney, breast, ovary, lung, nasopharynx, stomach, small bowel, colon, and prostate cancers. Leukocytoclastic vasculitis is most common in vasculitis induced by malignancy, but large-vessel vasculitis may also emerge. Paraneoplastic vasculitis should be kept in mind to accomplish early diagnosis and timely treatment of the underlying malignancy. Most paraneoplastic vasculitis requires no specific treatment other than that for the original malignancy.
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/1409323329 / rank
 
Normal rank
Property / CURIE
 
CID11:ID_1409323329
Property / CURIE: CID11:ID_1409323329 / rank
 
Normal rank
Property / Canary Token
 
dki-india-ID_1409323329
Property / Canary Token: dki-india-ID_1409323329 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
15 August 2026
Timestamp+2026-08-15T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 15 August 2026 / rank
 
Normal rank

Latest revision as of 12:39, 16 August 2026

Emergence of malignancy is reported in up to 5% of patients with vasculitis. In patients with malignancy and vasculitis, hematologic malignancies are most common. Vasculitis can also be associated with solid tumours: kidney, breast, ovary, lung, nasopharynx, stomach, small bowel, colon, and prostate cancers. Leukocytoclastic vasculitis is most common in vasculitis induced by malignancy, but large-vessel vasculitis may also emerge. Paraneoplastic vasculitis should be kept in mind to accomplish early diagnosis and timely treatment of the underlying malignancy. Most paraneoplastic vasculitis requires no specific treatment other than that for the original malignancy.
Language Label Description Also known as
default for all languages
ID_1409323329
    English
    Carcinoma-induced vasculitis
    Emergence of malignancy is reported in up to 5% of patients with vasculitis. In patients with malignancy and vasculitis, hematologic malignancies are most common. Vasculitis can also be associated with solid tumours: kidney, breast, ovary, lung, nasopharynx, stomach, small bowel, colon, and prostate cancers. Leukocytoclastic vasculitis is most common in vasculitis induced by malignancy, but large-vessel vasculitis may also emerge. Paraneoplastic vasculitis should be kept in mind to accomplish early diagnosis and timely treatment of the underlying malignancy. Most paraneoplastic vasculitis requires no specific treatment other than that for the original malignancy.

      Statements

      CID11:ID_1409323329
      0 references
      dki-india-ID_1409323329
      0 references
      Concluído
      0 references
      15 August 2026
      0 references